| Document Date: 2004-12-15 11:05:48
Open Document File Size: 89,49 KBShare Result on Facebook
Company PhD / / Country United States / / IndustryTerm pharmaceutical / / MedicalCondition insomnia / panic attacks / real illness / mania / Untreated depression / mental disorder / severe depression / restlessness / depression / adolescent depression / akathisia / Pediatric depression / / MedicalTreatment psychotherapy / cognitive behavioral therapy / / Organization U. S. Food and Drug Administration / FDA’s Advisory Committee / New York State office of Mental Health Sharon E. Carpinello / / Person Barbara L. Cohn / David J. Woodlock / / / Position psychiatrist / prescribing physician / physician / patient and parents/guardians / Commissioner / Executive / Deputy Commissioner and Director / Division of Children & Family Services Regarding Antidepressant Use / physician / Deputy Commissioner / / Product Venlafaxine / Wellbutrin / Effexor / Mirtazapine / Fluoxetine / Luvox / Celexa / Any Psychiatric Medication / Escitalopram / Lexapro / Remeron / Services Regarding Antidepressant / Zoloft / Prozac / Paxil / / Technology CBT / /
SocialTag |
New York State Office of Mental Health Sharon E. Carpinello, RN, PhD Commissioner Barbara L. Cohn